E. Read

发表

A multicenter comparison study between the Endosafe PTS rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products.

R. Lindblad, A. Gee, D. Sumstad, 2008, Cytotherapy.

A functional comparison of mature human dendritic cells prepared in fluorinated ethylene‐propylene bags or polystyrene flasks

E. Read, R. Kurlander, A. Tawab, 2006, Transfusion.

Innovation meets quality: moving cellular therapies at the National Institutes for Health from bench to bedside.

E. Read, 2004, Cytotherapy.

Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.

S. Holland, T. Fleisher, C. Maack, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.

Heather Kalish, Joseph A Frank, J. Frank, 2004, Blood.

Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma.

S M Larson, S. Larson, S. Rosenberg, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings

R. Knight, J. Frank, S. Anderson, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission

E. Read, R. Herron, D. Leiby, 2002, Transfusion.

Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome.

A. Barrett, R. Childs, E. Read, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy.

I. Pastan, M. Gottesman, D. Venzon, 1999, Blood.

Targeted pretransplant host lymphocyte depletion prior to T‐cell depleted reduced‐intensity allogeneic stem cell transplantation

S. Steinberg, M. Bishop, J. Gea-Banacloche, 2004, British journal of haematology.

Prolonged CD 4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults

C. Mackall, E. Read, L. Wexler, 2022 .

Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease.

A. Arai, R. Cannon, C. Dunbar, 2005, Journal of the American College of Cardiology.

Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).

N. Young, E. Read, S. Leitman, 1999, Human gene therapy.

Lack of sensitivity of indium-111 mixed leukocyte scans for active disease in Takayasu's arteritis.

J. Carrasquillo, G. Hoffman, E. Read, 1995, The Journal of rheumatology.

Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes

E. Read, R. Kurlander, A. Tawab, 2009, Transfusion.

Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.

S. Steinberg, B. Levine, C. June, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas

J. Berzofsky, L. Helman, C. Mackall, 2008, Clinical Cancer Research.

In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma.

S. Rosenberg, J. Carrasquillo, E. Read, 1989, Journal of the National Cancer Institute.

Transplant dose of CD34+ and CD3+ cells predicts outcome in patients with haematological malignancies undergoing T cell‐depleted peripheral blood stem cell transplants with delayed donor lymphocyte add‐back

R. Altemus, N. Young, A. Barrett, 2001, British journal of haematology.

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.

J. Gaglia, D. Harlan, K. Rother, 2003, Diabetes care.

Reconstitution of FOXP 3 regulatory T cells ( Tregs ) after CD 25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease

K. Rezvani, A. Barrett, V. Ghetie, 2007 .

Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.

K. Rezvani, A. Barrett, V. Ghetie, 2007, Blood.

Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease.

Michael L Kaufman, Aaron R Cooper, E. Grassman, 2017, Cytotherapy.

Enumeration of CD34+ hematopoietic progenitor cells in peripheral blood and leukapheresis products by microvolume fluorimetry: a comparison with flow cytometry.

H. Klein, E. Read, C. Carter, 1997, Journal of hematotherapy.

HEMATOLOGICAL EFFECTS OF AGING CONSIDERATIONS FOR CLINICAL TRIALS

H. Klein, E. Read, 1986 .

Therapeutic potential of mesenchymal stem cells for severe acute lung injury.

B. Thompson, M. Matthay, Kathleen D. Liu, 2010, Chest.

Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation.

J. Michálek, A. Barrett, V. Ghetie, 2002, Cytotherapy.

Feride-protamine sulfate labeling does not alter differentiation of mesenchymal stem cells

J. Frank, S. Anderson, A. Arbab, 2004 .

Enumeration of cells in bone marrow and peripheral blood stem cell collections: technical issues and prospects for standardization.

E. Read, C. Carter, 1992, Journal of hematotherapy.

Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.

N. Young, A. Barrett, N. Hensel, 1999, Blood.

Going where the action is: cellular therapy for diabetes mellitus.

E. Read, 2003, Cytotherapy.

Selection and expansion of T cell from untreated patients with CLL: source of cells for immune reconstitution?

J. Williams, E. Read, R. Gress, 2000, Cytotherapy.

Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation.

S. Solomon, A. Barrett, R. Childs, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mobilization, collection, and immunomagnetic selection of peripheral blood CD34 cells in recovered aplastic anemia patients

N. Young, P. Scheinberg, J. Maciejewski, 2007, Transfusion.

Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation

N. Young, A. Barrett, R. Childs, 2003, Bone Marrow Transplantation.

Fas‐mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous FasL‐expressing T cells

E. Read, R. Gress, V. Fellowes, 1999, British journal of haematology.

A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.

K. Rezvani, A. Barrett, E. Gostick, 2008, Blood.

Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy.

J. Berzofsky, C. Mackall, E. Read, 2001, Cytotherapy.

Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia.

K. Rezvani, A. Barrett, R. Childs, 2006, Blood.

Stimulatory effect of counterflow centrifugal elutriation in large‐scale separation of peripheral blood monocytes can be reversed by storing the cells at 37°c

E. Read, P. Pizzo, C. Carter, 1991, Journal of clinical apheresis.

Prospective evaluation of cell kinetics, yields and donor experiences during a single large‐volume apheresis versus two smaller volume consecutive day collections of allogeneic peripheral blood stem cells

A. Barrett, R. Childs, E. Read, 2003, British journal of haematology.

High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia.

N. Young, A. Barrett, A. Gratwohl, 2003, Blood.

Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study.

J. Berzofsky, L. Helman, C. Mackall, 2002, Medical and pediatric oncology.

Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.

W. Wilson, S. Steinberg, I. Pastan, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Management of severe VWD with cryoprecipitate collected by repeated apheresis of a single dedicated donor

G. Pomper, E. Read, S. Leitman, 2003, Transfusion.

Quality assurance for cell processing: no more blind faith

E. Read, 1996, Transfusion.

Allogeneic Human Mesenchymal Stem Cells Inhibit Bacterial Growth And Restore Normal Alveolar Fluid Transport In An Ex Vivo Perfused Human Lung Injured By Live E. Coli

M. Matthay, Xiaohui Fang, D. McKenna, 2011, ATS 2011.

American Thoracic Society Meeting 2011. Am. J. Respir. Crit. Care Med. 2011;183: A1247: Allogeneic Human Mesenchymal Stem Cells Inhibit Bacterial Growth and Restore Normal Lung Fluid Balance in an Ex Vivo Perfused Human Lung Injured by live E.coli.

M. Matthay, D. McKenna, E. Read, 2011 .

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.

S. Holland, A. Barrett, R. Childs, 2001, The New England journal of medicine.

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

A. Barrett, N. Hensel, V. Ghetie, 2005, Blood.

Differences in the Phenotype, Cytokine Gene Expression Profiles, and In Vivo Alloreactivity of T Cells Mobilized with Plerixafor Compared with G-CSF

J. P. McCoy, N. Geller, J. Joo, 2013, Journal of Immunology.

Plerixafor Compared with G-CSF Alloreactivity of T Cells Mobilized with Expression Profiles, and In Vivo Differences in the Phenotype, Cytokine Gene

J. P. McCoy, C. Dunbar, Susan Wong, 2013 .

Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors.

H. Klein, J. Esteban, E. Read, 1989, The New England journal of medicine.

Viability of platelets following storage in the irradiated state. A pair‐controlled study

E. Read, S. Leitman, C. Carter, 1988, Transfusion.

Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors.

E. Read, R. Dodd, L. Kirchhoff, 1997, The Journal of infectious diseases.

Blood collection and transfusion in the United States in 2001

E. L. Wallace, E. Read, M. Sullivan, 2007, Transfusion.

Qualification of cellular starting materials for cell-based therapies

Elizabeth Read, E. Read, 2019, Cell and Gene Therapy Insights.

Acute HIV infection presenting with painful swallowing and esophageal ulcers.

L. Rabeneck, E. Read, M. Popovič, 1990, JAMA.

Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA

P. Lansdorp, N. Young, E. Sloand, 2003, The Lancet.

Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.

P. Murray, F. Stock, E. Read, 2004, Cytotherapy.

Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

W. Linehan, N. Young, A. Barrett, 2000, The New England journal of medicine.

Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.

J. Berzofsky, J. Minna, D. Carbone, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.

S. Steinberg, M. Bishop, J. Gea-Banacloche, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences.

R. M. Childs, E. Read, C. Carter, 2002, Cytotherapy.

Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.

H Clifford Lane, J. Metcalf, M. Baseler, 2005, Human gene therapy.

Hematological Effects of Aging

H. Klein, E. Read, 1986 .

Flow cytometric detection of human red cells labeled with a fluorescent membrane label: potential application to in vivo survival studies

E. Read, M. Yu, L. L. Cardine, 1991, Transfusion.

Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait.

J. Tisdale, G. Rodgers, E. Read, 2002, Blood.

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

C. Dunbar, D. Couriel, E. Read, 1996 .

Lineage‐specific engraftment and outcomes after T‐cell‐depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning

R. Childs, E. Read, S. Leitman, 2005, British journal of haematology.

Evaluation of gene expression profiles of immature dendritic cells prepared from peripheral blood mononuclear cells

F. Marincola, E. Wang, D. Stroncek, 2008, Transfusion.

Bulk cryopreservation of lymphocytes in glycerol

E. Read, C. Carter, T. Simonis, 1988, Transfusion.

Hematopoietic progenitor cells.

E. Read, S. Leitman, 1996, Seminars in hematology (Print).

T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.

K. Rezvani, A. Barrett, R. Childs, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

J. Berzofsky, D. Douek, B. Hill, 2005, Nature Medicine.

Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease

J. P. McCoy, R. Cannon, T. Finkel, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Multiple‐laboratory comparison of in vitro assays utilized to characterize hematopoietic cells in cord blood

J. Reems, H. Eichler, E. Read, 2006, Transfusion.

Radiolabeled platelet survival studies

E. Read, C. Carter, 1986, Transfusion.

Development of graft-versus-host disease depends upon establishment of complete donor T cell chimerism after T cell depleted, reduced intensity hematopoietic stem cell transplantation

S. Steinberg, M. Bishop, E. Read, 2005 .

Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers.

E. Read, W. Kopp, C. Carter, 2002, Cytotherapy.